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Patients with chronic pain due to neuropathy or musculoskeletal injury frequently exhibit
reduced alpha and increased theta power densities. However, little is known about
electrical brain activity and chronic pain in patients with rheumatoid arthritis (RA). For
this purpose, we evaluated power densities of spontaneous electroencephalogram (EEG)
band frequencies (delta, theta, alpha, and beta) in females with persistent pain due to RA.
This was a cross-sectional study of 21 participants with RA and 21 healthy controls (mean
age = 47.20; SD = 10.40). EEG was recorded at rest over 5min with participant’s eyes
closed. Twenty electrodes were placed over five brain regions (frontal, central, parietal,
temporal, and occipital). Significant differences were observed in depression and anxiety
with higher scores in RA participants than healthy controls (p = 0.002). Participants with
RA exhibited increased average absolute alpha power density in all brain regions when
compared to controls [F(1.39) = 6.39, p = 0.016], as well as increased average relative
alpha power density [F(1.39) = 5.82, p = 0.021] in all regions, except the frontal region,
controlling for depression/anxiety. Absolute theta power density also increased in the
frontal, central, and parietal regions for participants with RA when compared to controls
[F(1, 39) = 4.51, p = 0.040], controlling for depression/anxiety. Differences were not
exhibited on beta and delta absolute and relative power densities. The diffuse increased
alpha may suggest a possible neurogenic mechanism for chronic pain in individuals
with RA.
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INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, autoimmune disease of unknown etiology (Firestein,
2003). A recent systematic literature review estimated the global prevalence to be 0.24% (95% CI:
0.23–0.25%; Cross et al., 2014). Gender plays an important role, as women are twice as likely to
present the condition (mean 0.35%; 95%CI: 0.34–0.37) thanmales (mean 0.13%; 95%CI: 0.12–0.13;
Mikkelsen et al., 1967).
Abbreviations: RA, rheumatoid arthritis; HC, healthy controls; HADS, Hospital Anxiety and Depression Scale; DN4,
Neuropathic Pain Diagnostic Questionnaire (Douleur Neuropathique 4); DAS28, Disease Activity Score in 28 Joints; ROI,
Regions of Interest.
Meneses et al. Quantitative EEG and Rheumatoid Arthritis
RA is characterized by peripheral and symmetric polyarthritis,
affecting the synovial membranes of joints, leading to pain, and
joint deformities (McInnes and Schett, 2011). RA was recently
associated with neuropathic pain (Mendes et al., 2014; Walsh
and McWilliams, 2014; Koop et al., 2015) which may be present,
among other factors, because of entrapment neuropathies,
the use of certain drugs and central sensitization. Pain is
perhaps the most common symptom and the most related to
disability in RA patients (Skevington, 1986; Firestein, 2003;
Walsh and McWilliams, 2014). However, the quantification and
characterization of pain is a challenge for clinicians, since the
experience of pain is individual and subjective (Pimenta and
Teixeira, 1996; de Vries et al., 2013). Scales and questionnaires
have been used in clinical practice to describe pain intensity, as
well as its temporal and qualitative aspects.
The electroencephalogram (EEG) is a promising tool for
pain evaluation in clinical settings (Jones et al., 2012), since it
can provide useful information about the central mechanisms
involved in the maintenance of chronic pain in rheumatic
diseases (Lee et al., 2011). In general, the assessment of EEG
characteristics during wakefulness demonstrated that chronic
neuropathic pain usually is associated with EEG slowing,
increased power density and peak frequency in the low frequency
ranges (theta, alpha; Boord et al., 2008; Olesen et al., 2011; de
Vries et al., 2013; Jensen et al., 2013; van den Broeke et al., 2013).
Several authors have further argued that EEG abnormalities in
chronic pain could be due to a dysfunction of top-down or
bottom-up thalamic modulation (thalamocortical dysrhythmia;
Llinás et al., 1999, 2005; Sarnthein et al., 2006). Moreover, the fact
that patients with chronic low back pain did not show a similar
pattern of EEG slowing seems to raise the question of whether
this could be a relevant marker for distinguishing between the
neuropathic and the nociceptive nature of pain (Schmidt et al.,
2012).
RA is fundamentally an inflammatory disease, associated with
severe and disabling pain. Although inflammation of joints and
other musculoskeletal tissues are the main sources of nociceptive
pain in RA (Schaible et al., 2002; Schaible, 2014), recent
studies have identified neuropathic pain components within the
symptoms of this disease (Ahmed et al., 2014; Mendes et al., 2014;
Koop et al., 2015). One of the main candidates to explain the
presence of neuropathic pain symptoms is central sensitization
(Ahmed et al., 2014). This condition is a consequence of
pathological enhancement in nociceptive neuronal function due
tomaintained nociceptive transmission or decreased endogenous
inhibition (Latremoliere and Woolf, 2009). Central sensitization
per se is associated to the development of neuropathic pain
complaints (Mease et al., 2011), which has been identified in
patients with RA (Meeus et al., 2012). This maladaptive condition
of the central nervous system may be related to spreading of
symptoms, decreased pain thresholds, and the poor relation
between disease activity and symptoms in RA (Atzeni et al., 2011;
Meeus et al., 2012; Hochman et al., 2013). Furthermore, these
modifications in the processing of pain at the central level have
already been characterized by somatosensory EEG event-related
potentials (Wendler et al., 2001), but not by EEG activity at
rest.
Given the combination of nociceptive and neuropathic pain
in RA, the investigation of quantitative EEG at rest may shed
light into its pathophysiology. It may also reveal whether
signs of thalamocortical dysrhythmia are present. Therefore, the
objectives of the current study were two-fold: (a) to compare EEG
activity at rest in patients with RA to healthy controls, and (b) to
evaluate the relationship between pain characteristics and EEG
activity in patients with RA.
MATERIALS AND METHODS
Participants
Twenty-one women with RA (mean = 47.92, SD = 12.36)
and 21 healthy controls (HC; mean = 46.41, SD = 8.30)
participated in this cross-sectional study and assessed between
August 2013 and October 2014. The participants with RA
were recruited from a third-party reference center in Bahia
(Brazil) and had received a diagnosis from a rheumatologist,
conforming with the criteria from the American College of
Rheumatology (Aletaha et al., 2010). Patients were included if
they were suffering from chronic pain (pain lasting more than 6
months), during more than 3 days per week, and predominantly
located in the joints associated or not with deformities and/or
joint range of motion. Participants were excluded if they were
diagnosed with any other rheumatologic disease in addition
to RA, or reported the use of centrally acting substances.
The control group did not report chronic pain and was pain-
free on the day of the experiment. Three milliliters of venous
blood were collected from the participants with RA in order
to analyze the Erythrocyte Sedimentation Rate and C-reactive
protein.
Table 1 presents sociodemographic and clinical characteristics
for the entire sample and the two groups, as well as the results
of tests comparing averages and proportions for the two groups.
Significant differences between RA patients HC only appeared in
anxiety/depression scores.
The average duration of the disease in the group of
participants with RA was 107.4 ± 45.9 months, with an average
medical follow-up time of 93.4 ± 43.4 months. The medications
most frequently used by these participants were Metotrexate
(52.4%), Infliximab (19%), and Prednisone (38.1%). Most of the
RA patients reported high (n = 8) or moderate (n = 10) disease
activity. Only two patients were in remission and one presented
low disease activity. Themain neuropathic pain descriptors (DN4
questionnaire) were numbness (71.4%), tingling (61.9%), and
electric shock (57.1%). A total of 57.1% of the RA participants
reported neuropathic pain, according to the DN4. The clinical
pain characteristics of RA participants are described in detail in
Table 2.
Participants were verbally informed about the details of the
study and all questions answered at the time of recruitment. After
agreeing to participate, a written consent was obtained and a
printed copy was provided to subjects. The study was conducted
in compliance with the principles of the Declaration of Helsinki,
and was approved by the Research Ethics Committee at the Escola
Bahiana de Medicina e Saúde Pública (Bahia School of Medicine
and Public Health; reference #1395/2011).
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TABLE 1 | Comparison of demographic, behavioral, and clinical characteristics of women with Rheumatoid Arthritis and Healthy Controls.
Total sample (n = 42) Healthy controls (n = 21) RA Patients (n = 21) p-value
N (%) or average (SD) N (%) or average (SD) N (%) or average (SD)
DEMOGRAPHIC CHARACTERISTICS
Age, in years 47.16 (10.42) 46.41(8.30) 47.92 (12.36) 0.64
Variation (min - max) – 33–59 23–69
Level of education 0.08
HS incomplete 11 (26.19) 4 (19.05) 7 (33.33)
Completed HS – some College 20 (47.62) 8 (38.10) 12 (57.14)
College or higher 11 (26.19) 9 (42.86) 2 (9.52)
Race/color 0.54
White 3 (7.14) 2 (9.52) 1 (4.76)
Black/Afro-Brazilian 21 (50) 9 (42.86) 12 (57,14)
Mixed race 13 (30.95) 6 (28.57) 7 (33.33)
Othersa 5 (11.90) 4 (19.05) 1 (4.76)
Marital Status 0.31
Single 11 (26.19) 3 (14.29) 8 (38.1)
Married/Live with partner 20 (47.62) 12 (57.14) 8 (38.1)
Separated/Divorced/ Widow(er) 11 (26.19) 6 (28.57) 5 (23.81)
HEALTH BEHAVIOR
Smoking 0.76
No 31 (73.81) 16 (76.19) 15 (71.43)
Yes 8 (19.05) 3 (14.29) 5 (23.81)
Former smoker 3 (7.14) 2 (9.52) 1 (4.76)
Alcohol consumption 0.06
Never 23 (54.76) 8 (38.10) 15 (71.43)
Occasionallyb 19 (45.24) 13 (61.90) 6 (28.57)
Physical activity 0.31
Sedentary 20 (47.62) 8 (38.10) 12(57.14)
Occasionally 9 (21.43) 4(19.05) 5(23.81)
Moderate/intense 13 (30.95) 9(42.86) 4(19.05)
CLINICAL CHARACTERISTICS
Diabetes Mellitus 3 (7.14) 2 (9.52) 1 (4.76) 1.00
Thyroid problem 10 (23.81) 4 (19.05) 6 (28.57) 0.72
Laterality in upper limb 1.00
Right 39 (92.86) 20 (95.24) 19 (90.48)
Left 3 (7.14) 1 (4.76) 2 (9.52)
Depression/Anxiety (HADS) 0.002*
With anxiety and/or depression 19 (45.24) 4 (19.05) 15 (71.43)
Differences were tested for continuous variables between the groups using the Student’s t-test and for categories using Fisher’s exact test.
*Significant at level 0.05.
SD, Standard Deviation; RA, Rheumatoid Arthritis; HS, High School; HADS, Hospital Anxiety and Depression Scale.
aOthers, the sum of individuals auto-declared “Yellow/Oriental” and “Red/Indian.”
bOccasionally, weekends without any incidents of drunkenness. The original categories in this variable also included the following options: occasionally with incidents of drunkenness;
frequently without any incidents of drunkenness and frequently with incidents of drunkenness. None of the participants selected these options.
Psychological Questionnaires
All participants underwent a semi-standardized interview,
including socio-demographic data (age, marital status, level
of education, alcohol consumption, smoking, and practice of
physical activities) and assessment of mood through the Hospital
Anxiety and Depression Scale (HADS). The HADS is a 14-items
questionnaire for the assessment of anxiety and depression
symptoms (Bjelland et al., 2002). The maximum score on the
depression subscale is 21, with a cut-off point at nine. The
maximum score on the anxiety subscale is also 21, with a cut-off
point at seven. We used an adapted and validated Brazilian
version of this scale (Castro et al., 2006).
The following questionnaires were completed by participants
with RA only:
McGill Pain Questionnaire. This questionnaire evaluates the
subjective and multidimensional experience of pain, providing
quantitativemeasures of clinical pain. It comprises the following
Frontiers in Human Neuroscience | www.frontiersin.org 3 August 2016 | Volume 10 | Article 395
Meneses et al. Quantitative EEG and Rheumatoid Arthritis
TABLE 2 | Characteristics of the pain in patients with Rheumatoid Arthritis.
CHARACTERISTICS OF THE PAIN





Neuropathic paina N (%)
With neuropathic pain 12 (57.14)
Without neuropathic pain 9 (42.86)
Average (SD)
Number of pain descriptors (McGill) 13.57 (5.90)
McGill pain index 28.14 (13.37)
SD, Standard Deviation.
aEvaluated using the Douleur Neuropathique 4 (DN4) questionnaire, with a variation of
between 0 and 10 and average of 4.10 (DP = 2.51). Patients with neuropathic pain were
those with a score equal to or higher than 4.0.
Number of pain descriptors and McGill pain index: measured using the McGill Scale
(1996).
categories of pain descriptors: sensitive-discriminative;
affective-motivational; cognitive-evaluative; and miscellaneous
(Melzack, 1975). In the present study, we used an adapted and
validated Brazilian version of this questionnaire (Pimenta and
Teixeira, 1996). The maximum “number of pain descriptors” is
20. The “total pain level” was defined as the sum of values for
pain intensity, with a maximum score of 78.
The Neuropathic Pain Diagnostic Questionnaire (Douleur
Neuropathique 4 - DN4). This 10-item questionnaire was
designed to assess neuropathic pain and includes pain
descriptors (7 items) and a bedside examination (3 items;
Bouhassira et al., 2005). The final score falls within a scale
from 0 to 10. Scores higher than three indicate the presence of
neuropathic pain. We used a validated Brazilian version of this
questionnaire (Santos et al., 2010).
Disease Activity Score in 28 Joints (DAS28). The goal
of the questionnaire is to evaluate the level of disease
activity in RA patients (Prevoo et al., 1995). It assesses
28 joints (shoulders, elbows, wrists, proximal interphalangeal
and metacarpophalangeal, and knees, bilaterally), counting
the number of painful joints without considering pain
intensity. A joint is considered “painful” if some level of
discomfort is present, even if the pain is not intense. The
total score varies from 0 to 10. Activity level was classified
according to the following cut-off points: remission ≤ 2.6;
low ≤ 3.2; moderate ≤ 5.1; and high activity > 5.1 (Pinheiro,
2007).
EEG Recording
EEG data were recorded using a standard amplifier (BRAINNET
36, EMSA Brazil) from 20 electrodes and two references located
on the auricular region (A1 and A2). Active EEG electrodes
were placed according to the international 10–20 system at
following locations: F7, T3, T5, Fp1, F3, C3, P3, O1, F8, T4,
T6, Fp2, F4, C4, P4, O1, Fz, Cz, Pz, and Oz. The sampling
rate was 200Hz and a ground electrode was placed in the
frontal region (Fpz). Electrode impedance was kept below 5 k.
Participants were instructed to stay relaxed with eyes closed but
were monitored so that they were awake throughout the 5min
recording.
The EEG data were analyzed by using the EEGLAB software
(version 13). The signals were filtered with a band-pass filter
between 0.5 and 50Hz. Continuous EEG data were segmented
in epochs of 1.28 s, which allowed a consistent evaluation of
power densities in the frequency range of 1.5–30Hz. A semi-
automated rejection protocol was used to remove artifacts, with
an upper limit of 1000µV and a lower limit of −1000µV. After
the artifact rejection protocol, a minimum of 170 epochs were
kept for each participant, an equivalent to roughly 3.5min. Since
we had decided to analyze 2min for each participant, we selected
the central epochs in order to standardize the selection process
and avoid selection bias. Thus, only data between epochs 50
and 142 (93 epochs, nearly 2min) of the EEG recording were
analyzed.
Power spectra were calculated by applying a fast Fourier
transform for each epoch. Power densities of each epoch
and electrode were averaged separately for each participant.
The average power densities were grouped into delta [1.5–
3.5Hz], theta [4–7Hz], alpha [8–12Hz], and beta [13–30Hz]
frequency bands. In addition, regions of interest (ROI) were
computed by averaging power densities at the four frequency
bands for the following groups of electrodes: frontal (Fp1,
Fp2, F3, Fz, F4), central (C3, Cz, C4), parietal (P3, Pz, P4),
occipital (O1, Oz, O2), and temporal (T3, T5, T4, T6). After
processing data for absolute power densities, the same was
done for relative power densities. These were computed dividing
electrode’s values in each one of the analyzed frequencies by
their values in the total power spectrum. The results for relative
power density were also analyzed and displayed by the same
ROIs.
Statistical Analysis
Data from the questionnaires were analyzed by using Student
t-tests to examine differences between the two groups. The
differences on the categorical variables were analyzed by using
Fisher’s Exact Test, as cells with a frequency equal to or
less than five were observed in the bivariate analyses. After
confirming normality of the data by using Shapiro–Wilk test
and Q-Q plots, differences in absolute and relative EEG power
densities between the groups was analyzed by using repeated-
measures ANOVA with the factors “group” and “region” (ROI)
after controlling for anxiety/depression symptoms. Violations
of sphericity assumption were corrected by using Greenhouse-
Geisser epsilons.
Finally, Pearson zero-order correlations were computed
between mean power densities and pain variables (disease
activity, neuropathic/nociceptive pain, and McGill outcome
variables). All pain variables were normally distributed
(using Kolmogorov–Smirnov test). A p-value of 5%
was used to accept statistically significant differences
between the two groups. The p-value was corrected for
multiple comparisons using the Bonferroni method when
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necessary. The SPSS 20.0 software package was used for all
analyses.
RESULTS
Difference between Groups on EEG
Absolute Power Density
An ANOVA looking at the full power spectrum (1.5–30Hz)
yielded a significant effect of “group” [F(1, 39) = 5.12,
p = 0.029], indicating that patients displayed overall higher
power density than HC. We also found a significant “region”
effect [F(4, 156) = 18.27, p < 0.0.0000001, epsilon GG= 0.595].
Although there were non-significant differences due to the
interaction between group and region [F(4, 156) = 0.51,
p = 0.605, epsilon GG = 0.505], mean comparisons in
the post-hoc analysis (using Bonferroni correction to adjust for
multiple comparisons) revealed that RA patients displayed higher
power density than HC at frontal (mean difference = 1.589,
p = 0.026), central (mean difference = 2.006, p = 0.015),
temporal (mean difference = 1.772, p = 0.040), and parietal
(mean difference= 2.178, p = 0.038) electrodes. After observing
this difference in the full power spectrum, we proceeded to look
at frequencies of interest. Our discussion will focus on the four
frequency bands reported below. Table 3 and Figure 1 display
the average absolute power density values for the analyzed EEG
frequency bands (delta, theta, alpha, and beta) across the five
ROIs.
Delta (1.5–3.5Hz)
The ANOVA yielded only a significant effect due to “region”
[F(4, 156) = 15.39, p < 0.0000001, epsilon GG = 0.640]. No
significant effects of “group” [F(1, 39) = 2.36, p = 0.132] or
the interaction between “group” and “region” [F(4, 156) = 0.535,
p = 0.631, epsilon GG = 0.470] were observed on absolute delta
power densities.
Theta (4–7Hz)
The ANOVA yielded a significant effect of “group”
[F(1, 39) = 4.51, p = 0.040], indicating that patients
displayed higher absolute theta power density than HC. We
also found a significant “region” effect [F(4, 156) = 18.22,
p < 0.0000001, epsilon GG = 0.634], showing that highest
power densities were found at parietal, and central electrodes,
whereas the lowest ones appeared at frontal electrodes. Although
there were non-significant differences due to the interaction
between group and region [F(4, 156) = 0.71, p = 0.526, epsilon
GG = 0.634], mean comparisons in the post-hoc analysis (using
Bonferroni correction to adjust for multiple comparisons)
revealed that RA patients displayed higher absolute theta power
density than HC at frontal (mean difference= 1.530, p = 0.039),
central (mean difference= 2.023, p = 0.024), and parietal (mean
difference= 2.067, p = 0.043) electrodes.
Alpha (8–12Hz)
The ANOVA yielded a significant effect of “group”
[F(1, 39) = 6.39, p = 0.016], indicating that patients
displayed higher absolute alpha power density than controls.
TABLE 3 | Average absolute power density values by regions of interest,
controlling for symptoms of anxiety/depression.
Frequency bands Controls RA Patients F(1.39) P-value
(Regions of Interest) (n = 21) (n = 21)
Delta (1.5–3.5Hz) 2.363 0.132
Frontal 28.86 (1.29) 28.88 (2.09)
Central 27.79 (1.50) 28.07 (1.88)
Temporal 26.82 (1.75) 26.74 (1.70)
Parietal 27.96 (1.82) 28.10 (1.76)
Occipital 27.16 (1.86) 27.14 (1.78)
Theta (4–7Hz) 4.505 0.040*
Frontal 25.82 (1.54) 27.03 (2.31)
Central 25.96 (2.16) 27.57 (2.55)
Temporal 24.51 (2.13) 25.73 (2.41)
Parietal 26.28 (2.42) 27.93 (2.98)
Occipital 25.80 (2.54) 27.23 (2.89)
Alpha (8–12Hz) 6.385 0.016*
Frontal 23.31 (3.17) 26.18 (3.30)
Central 24.68 (4.01) 28.24 (3.76)
Temporal 23.67 (3.68) 26.47 (4.07)
Parietal 25.96 (4.72) 29.78 (4.80)
Occipital 26.20 (4.72) 29.14 (4.93)
Beta (13–30Hz) 3.352 0.075
Frontal 16.73 (1.80) 17.87 (1.79)
Central 17.14 (1.94) 18.36 (1.76)
Temporal 16.53 (1.97) 17.37 (2.12)
Parietal 17.74 (2.45) 18.77 (2.35)
Occipital 17.69 (2.36) 18.38 (2.77)
*Significant at level 0.05. ANOVA of repeated measures.
We also found a significant “region” effect [F(4, 156) = 37.222,
p < 0.0000001, epsilon GG= 0.480] showing that highest power
densities were found at parietal, occipital, and central electrodes,
whereas the lowest ones appeared at frontal and temporal
electrodes. Although there were non-significant differences due
to the interaction between group and region [F(4, 156) = 1.69,
p = 0.192, epsilon GG = 0.480], mean comparisons in the
post-hoc analysis (using Bonferroni correction to adjust for
multiple comparisons) revealed that RA patients displayed
higher absolute alpha power density than HC at all five ROIs:
frontal (mean difference = 3.019, p = 0.015), central (mean
difference = 3963, p = 0.008), temporal (mean difference =
3.317, p = 0.025), parietal (mean difference = 4.437, p = 0.015),
and occipital (mean difference= 3783, p = 0.035).
Beta (13–30Hz)
The ANOVA yielded only a significant effect due to “region”
[F(4, 156) = 8.97, p = 0.000207, epsilon GG = 0.538]. No
significant effects of “group” [F(1, 39) = 3.35, p = 0.075] or
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FIGURE 1 | Comparison of absolute mean power densities (µ V2/Hz) for delta, theta, alpha, and beta bands between patients with rheumatoid arthritis
and healthy controls in five brain regions. An asterisk indicates significant statistical difference (p < 0.05).
the interaction between “group” and “region” [F(4, 156) = 0.12,
p = 0.997, epsilon GG = 0.538] were observed on absolute beta
power densities.
Difference between Groups on EEG
Relative Power Density
Table 4 and Figure 2 show the average relative power density
values for the analyzed EEG frequency bands (delta, theta, alpha,
and beta) across the five ROIs.
Delta (1.5–3.5Hz)
The ANOVA yielded only a significant effect due to “region”
[F(4, 156) = 22.89, p < 0.0000001, epsilon GG = 0.582]. No
significant effects of “group” [F(1, 39) = 3.16, p = 0.083] or the
interaction between “group” and “region” [F(4, 156) = 0.021,
p = 987, epsilon GG = 0.582] were observed on relative delta
power densities.
Theta (4–7Hz)
The ANOVA yielded only a significant effect due to “region”
[F(4, 156) = 12.63, p = 0.000041, epsilon GG = 0.554]. No
significant effects of “group” [F(1, 39) = 0.56, p = 0.457] or
the interaction between “group” and “region” [F(4, 156) = 0.053,
p = 960, epsilon GG = 0.554] were observed on relative theta
power densities.
Alpha (8–12Hz)
The ANOVA yielded a significant effect of “group”
[F(1, 39) = 5.82, p = 0.021], indicating that patients displayed
higher relative alpha power density than controls. We also found
a significant “region” effect [F(4, 156) = 23.09, p < 0.0000001,
epsilon GG = 0.613] showing that highest relative power
densities were found at parietal and occipital electrodes, whereas
the lowest ones appeared at central and temporal electrodes.
Although there were non-significant differences due to the
interaction between group and region [F(4, 156) = 0.83, p = 0.46,
epsilon GG = 0.613], mean comparisons in the post-hoc analysis
(using Bonferroni correction to adjust for multiple comparisons)
revealed that RA patients displayed higher relative alpha power
density than HC at four ROIs: central (mean difference = 0.077,
p = 0.020), temporal (mean difference = 0.064, p = 0.039),
parietal (mean difference = 0.087, p = 0.008), and occipital
(mean difference= 0.075, p = 0.034).
Beta (13–30Hz)
The ANOVA yielded no significant effect due to “region”
[F(4, 156) = 1.22, p = 0.304, epsilon GG = 0.580],
“group” [F(1, 39) = 0.44, p = 0.511] or the interaction
between “group” and “region” [F(4, 156) = 0.26, p = 0.803,
epsilon GG = 0.580] were observed on relative beta power
densities.
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TABLE 4 | Average relative power density values by regions of interest,
controlling for symptoms of anxiety/depression.
Frequency bands Controls RA Patients F(1.39) P-value
(Regions of Interest) (n = 21) (n = 21)
Delta (1.5–3.5Hz) 3.159 0.083
Frontal 1.44 (0.12) 1.35 (0.11)
Central 1.36 (0.09) 1.27 (0.11)
Temporal 1.37 (0.11) 1.29 (0.15)
Parietal 1.33 (0.12) 1.24 (0.12)
Occipital 1.30 (0.11) 1.23 (0.14)
Theta (4–7Hz) 0.565 0.457
Frontal 1.28 (0.07) 1.26 (0.07)
Central 1.27 (0.07) 1.24 (0.07)
Temporal 1.24 (0.07) 1.23 (0.08)
Parietal 1.24 (0.08) 1.23 (0.08)
Occipital 1.23 (0.07) 1.23 (0.09)
Alpha (8–12Hz) 5.823 0.021*
Frontal 1.15 (0.10) 1.21 (0.08)
Central 1.19 (0.10) 1.27 (0.08)
Temporal 1.19 (0.08) 1.26 (0.08)
Parietal 1.21 (0.09) 1.30 (0.08)
Occipital 1.23 (0.09) 1.30 (0.10)
Beta (13–30Hz) 0.440 0.511
Frontal 0.83 (0.04) 0.83 (0.03)
Central 0.83 (0.04) 0.83 (0.03)
Temporal 0.83 (0.03) 0.83 (0.04)
Parietal 0.83 (0.03) 0.82 (0.03)
Occipital 0.84 (0.03) 0.82 (0.05)
*Significant at level 0.05. ANOVA of repeated measures.
Relationship between Pain Characteristics
and Absolute and Relative EEG Activity
Correcting for multiple comparisons using Bonferroni method,
none of the Pearson correlations between pain characteristics and
power density in the delta, theta, alpha, and beta EEG frequency
bands were significant.
DISCUSSION
This study showed that participants with RA and chronic pain
presented higher theta and alpha absolute power densities at
rest in comparison to healthy individuals, whereas no group
differences were found for absolute power density of the beta and
delta EEG band. When looking at relative power densities, we
only found group differences in the alpha band.
Ourmost consistent finding was in the alpha frequency, which
was increased among participants with RA for both absolute
and relative power densities. We progressed from absolute to
relative power analysis because there was an increase in the total
spectrum power density for the RA group. If we solely assessed
absolute power density, as have the majority of large studies in
this area (Pinheiro et al., 2016), we would not be able to state
that there were specific differences between groups, since these
differences could be related to the general increase in the total
spectrum power density.
The increased alpha band power density in RA participants
seems to be associated with specific pathological characteristics
of the disease. Earlier studies have shown similar results in
conditions of mental fatigue (Tran et al., 2014) and emotional
stress (Vanneste et al., 2014), which are characteristic symptoms
of patients with RA. In this sense, increased alpha power
density has already been shown in individuals with tinnitus
(Vanneste et al., 2014). Moreover, Sarnthein and Jeanmonod
found increased spectral power density in the lower alpha range
(7–9Hz) in all cerebral regions in patients with neurogenic pain
(Sarnthein and Jeanmonod, 2008). Similar results have also been
evident in individuals with neuropathic pain due to spinal cord
injury (Jensen et al., 2013), chronic pancreatitis (Drewes et al.,
2008), and breast cancer (van den Broeke et al., 2013).
It is possible that the constant awareness in the expectation
of pain may play a role in the increase of alpha power at
rest (Babiloni et al., 2008, 2010). Previous studies have already
shown that pain expectation activates the pain network, including
“emotional” areas (Sawamoto et al., 2000; Koyama et al., 2005),
and modulates alpha activity (Franciotti et al., 2009). However,
the majority of studies that investigated the association between
alpha related synchronization/desynchronization and pain used
experimental paradigms (Peng et al., 2015). A recent review
(Pinheiro et al., 2016) showed that alpha power may be increased
in the resting state EEG, but the mechanisms for such increase
still need to be investigated in depth. We did find group
differences on depression/anxiety, leading us to control for these
variables in the ANOVAs with the EEG data. Thus, we feel that
the increase on alpha frequency in RA participants as compared
to healthy controls was not influenced by participant’s high levels
of anxiety/depression.
Our results also revealed an increase in absolute theta power
density in the participants with RA. This finding cannot be
considered specific because of the increase in total spectral power
seen in this group. However, the findings are in agreement
with previous studies, showing increased theta power density
in patients with migraine, fibromyalgia, neuropathic pain, and
chronic pain secondary to low back pain (Sarnthein et al., 2006;
Stern et al., 2006; Bjørk et al., 2009; Jensen et al., 2013; Vuckovic
et al., 2014). Thalamic dysregulations such as thalamocortical
dysrhythmia (TCD) have been described in individuals with
neuropathic pain and could possibly explain our findings of
enhanced absolute theta power density in RA patients (Sarnthein
et al., 2006; Walton and Llinas, 2010; de Vries et al., 2013).
Previous studies have shown that increased theta power density
in patients with chronic neuropathic pain may be related to
thalamic disinhibition due to decreased top-down or bottom-
up modulation (Llinás et al., 1999, 2005; Sarnthein et al., 2006).
In this sense, Stern et al. described increased theta power
density in multiple areas of the pain matrix, including parietal
cortices, somatosensory cortices, and mid- and dorsolateral
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FIGURE 2 | Comparison of relative mean power densities (µ V2/Hz) for delta, theta, alpha, and beta bands between patients with rheumatoid arthritis
and healthy controls in five brain regions. An asterisk indicates significant statistical difference (p < 0.05).
prefrontal cortices of patients with neuropathic pain (Stern et al.,
2006). These same authors argued that thalamic deactivation
could be considered as the neurophysiological basis of chronic
neurogenic pain. Furthermore, Sarnthein et al. hypothesized
that neurogenic pain could be originated by deafferentation of
excitatory inputs in the thalamus, leading to cell membrane
hyperpolarization (Sarnthein et al., 2006). In this hyperpolarized
state, thalamic interneurons appears to fire at a frequency range
similar to the theta activity. Recent studies have shown that many
RA patients reported neuropathic pain from different origins
(Mendes et al., 2014; Walsh and McWilliams, 2014; Koop et al.,
2015), including pain as a consequence of the use of TNF-
alpha inhibitors (Birnbaum and Bingham, 2014), neurogenic
inflammation (Seidel et al., 2010), and central sensitization
(Meeus et al., 2012).
We also observed that RA participants and HC did not differ
in delta and beta power densities at any of the ROI. A lack
of statistical significance for these group differences may be
attributed to a type II error in our study. At one hand, some
of the previous studies observed differences on both delta and
beta bands between patients with chronic pain and controls. For
instance, Sarnthein et al. showed an increase in the total EEG
spectrum in patients with neurogenic pain, including the delta
and beta ranges (Sarnthein et al., 2006). They attributed these
changes to TCD, as described above in the discussion of theta
band changes. On the other hand, previous studies in patients
with neuropathic chronic pain have failed to find differences
between patients and HC in both delta (Bjørk et al., 2009) and
beta (Vuckovic et al., 2014) EEG bands.
In this study we did not find any correlations between
absolute and relative power densities and McGill scores,
after controlling for depression. Correlations between pain
characteristics (intensity and/or duration) and EEG power
density are controversial. Schmidt et al. found a positive
correlation between alpha power density and pain intensity, not
at the moment of EEG evaluation but only on the one referenced
in the previous 12 months (Schmidt et al., 2012). de Vries et al.
only found a positive correlation between alpha peak frequency
(but not power density) and pain duration, but not pain intensity
(de Vries et al., 2013). On the other hand, other studies failed to
find significant correlations between EEG power density and pain
intensity (Jensen et al., 2007; van den Broeke et al., 2013).
Although it remains a matter of controversy, the presence of
neuropathic symptoms in RA seems to be related to the presence
of central sensitization, rather than a lesion of the somatosensory
system itself. Since central sensitization involves the spinal cord
and brain, neuropathic symptoms may be referred, even if pain
is from nociceptive origin. Neuropathic pain symptoms have
been identified in RA with another instrument, the PAINDetect
(Koop et al., 2015; Christensen et al., 2016), which has different
psychometric properties than the DN4. The DN4 has good
properties to identify pain due to lesions of the somatosensory
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system, but most likely would not identify central sensitization
adequately, as seen in Ehlers-Danlos syndrome patients (Di
Stefano et al., 2016). Thus, central sensitization may have been
underdiagnosed in our sample, which prevented us to identify
associations between EEG variables and neuropathic pain. Future
studies should use other measures of central sensitization to
better classify patients and reveal if this condition has a typical
EEG pattern.
As this was an initial exploratory study, the sample size did not
allow us to identify whether the main findings were related to the
nature of the pain or even to the use of medication to treat RA
symptoms, since only two participants in the RA group were not
taking medications. A third group of individuals with RA and a
low level of disease activity would be required in future studies to
establish a clearer relation between the observed findings and the
disease itself, independent of the presence of pain.
CONCLUSION
Our data suggest that subjects with RA present
electroencephalographic characteristics similar to patients
with chronic pain due to other etiologies. Increased absolute
and relative alpha power densities at rest could be used as a
general marker for the presence of chronic pain in patients
with RA. This increase in alpha power density may also help to
understand brain dysfunction associated with chronic pain in
this population, as well as using it to develop new interventions
to treat this condition.
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